Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarction
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1016/j.ijcard.2011.12.097 http://repositorio.unifesp.br/handle/11600/36550 |
Resumo: | Background: the aim of the present study was to evaluate if the influence of digitalis on survival depends on the severity of cardiac dysfunction in heart failure (HF).Methods and results: Doppler echocardiogram (DE) parameters were analyzed in 84 Wistar control (C) and 80 Wistar rats treated with 0.1 mg/100 g/day of digitoxin (D) five days after coronary occlusion. the de variables correlated with the survival of the animals were: myocardial infarction size, left chamber dimensions, fractional area change and E/A ratio. the animals were observed for up to 280 days. Mortality was worsened in rats in the D group with a myocardial infarction (MI) < 37% and with better de predictors of survival. Digitoxin was found to prolong survival in rats with an MI >= 37% and worse de predictors.Conclusion: for the first time our study has shown experimentally that the action of digitalis glycosides can positively or negatively influence survival during treatment of HF. It prolongs survival of those in advanced state and compromises survival when there is less severity of the disease. in fact, the greater benefits occur when digitoxin was used in heightened ventricular dilatations and worse ventricular performance. (c) 2011 Elsevier Ireland Ltd. All rights reserved. |
id |
UFSP_3d934468f9cadb2bcda219b8c0876501 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/36550 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarctionDigitalisSurvivalMyocardial infarctionHeart failureRatsBackground: the aim of the present study was to evaluate if the influence of digitalis on survival depends on the severity of cardiac dysfunction in heart failure (HF).Methods and results: Doppler echocardiogram (DE) parameters were analyzed in 84 Wistar control (C) and 80 Wistar rats treated with 0.1 mg/100 g/day of digitoxin (D) five days after coronary occlusion. the de variables correlated with the survival of the animals were: myocardial infarction size, left chamber dimensions, fractional area change and E/A ratio. the animals were observed for up to 280 days. Mortality was worsened in rats in the D group with a myocardial infarction (MI) < 37% and with better de predictors of survival. Digitoxin was found to prolong survival in rats with an MI >= 37% and worse de predictors.Conclusion: for the first time our study has shown experimentally that the action of digitalis glycosides can positively or negatively influence survival during treatment of HF. It prolongs survival of those in advanced state and compromises survival when there is less severity of the disease. in fact, the greater benefits occur when digitoxin was used in heightened ventricular dilatations and worse ventricular performance. (c) 2011 Elsevier Ireland Ltd. All rights reserved.Universidade Federal de São Paulo, Div Cardiol, São Paulo, BrazilUniversidade Federal de São Paulo, Div Cardiol, São Paulo, BrazilWeb of ScienceFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)FAPESP: 09/54225-8CNPq: 300737/2009-2Elsevier B.V.Universidade Federal de São Paulo (UNIFESP)Santos, Alexandra Alberta dos [UNIFESP]Helber, Izo [UNIFESP]Antonio, Ednei Luiz [UNIFESP]Franco, Marcelo Fabiano de [UNIFESP]Tucci, Paulo José Ferreira [UNIFESP]2016-01-24T14:32:00Z2016-01-24T14:32:00Z2013-07-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion357-361application/pdfhttp://dx.doi.org/10.1016/j.ijcard.2011.12.097International Journal of Cardiology. Clare: Elsevier B.V., v. 167, n. 2, p. 357-361, 2013.10.1016/j.ijcard.2011.12.097WOS000320768800019.pdf0167-5273http://repositorio.unifesp.br/handle/11600/36550WOS:000320768800019engInternational Journal of Cardiologyinfo:eu-repo/semantics/openAccesshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policyreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-31T13:05:18Zoai:repositorio.unifesp.br/:11600/36550Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-07-31T13:05:18Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarction |
title |
Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarction |
spellingShingle |
Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarction Santos, Alexandra Alberta dos [UNIFESP] Digitalis Survival Myocardial infarction Heart failure Rats |
title_short |
Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarction |
title_full |
Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarction |
title_fullStr |
Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarction |
title_full_unstemmed |
Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarction |
title_sort |
Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarction |
author |
Santos, Alexandra Alberta dos [UNIFESP] |
author_facet |
Santos, Alexandra Alberta dos [UNIFESP] Helber, Izo [UNIFESP] Antonio, Ednei Luiz [UNIFESP] Franco, Marcelo Fabiano de [UNIFESP] Tucci, Paulo José Ferreira [UNIFESP] |
author_role |
author |
author2 |
Helber, Izo [UNIFESP] Antonio, Ednei Luiz [UNIFESP] Franco, Marcelo Fabiano de [UNIFESP] Tucci, Paulo José Ferreira [UNIFESP] |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Santos, Alexandra Alberta dos [UNIFESP] Helber, Izo [UNIFESP] Antonio, Ednei Luiz [UNIFESP] Franco, Marcelo Fabiano de [UNIFESP] Tucci, Paulo José Ferreira [UNIFESP] |
dc.subject.por.fl_str_mv |
Digitalis Survival Myocardial infarction Heart failure Rats |
topic |
Digitalis Survival Myocardial infarction Heart failure Rats |
description |
Background: the aim of the present study was to evaluate if the influence of digitalis on survival depends on the severity of cardiac dysfunction in heart failure (HF).Methods and results: Doppler echocardiogram (DE) parameters were analyzed in 84 Wistar control (C) and 80 Wistar rats treated with 0.1 mg/100 g/day of digitoxin (D) five days after coronary occlusion. the de variables correlated with the survival of the animals were: myocardial infarction size, left chamber dimensions, fractional area change and E/A ratio. the animals were observed for up to 280 days. Mortality was worsened in rats in the D group with a myocardial infarction (MI) < 37% and with better de predictors of survival. Digitoxin was found to prolong survival in rats with an MI >= 37% and worse de predictors.Conclusion: for the first time our study has shown experimentally that the action of digitalis glycosides can positively or negatively influence survival during treatment of HF. It prolongs survival of those in advanced state and compromises survival when there is less severity of the disease. in fact, the greater benefits occur when digitoxin was used in heightened ventricular dilatations and worse ventricular performance. (c) 2011 Elsevier Ireland Ltd. All rights reserved. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-07-31 2016-01-24T14:32:00Z 2016-01-24T14:32:00Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.ijcard.2011.12.097 International Journal of Cardiology. Clare: Elsevier B.V., v. 167, n. 2, p. 357-361, 2013. 10.1016/j.ijcard.2011.12.097 WOS000320768800019.pdf 0167-5273 http://repositorio.unifesp.br/handle/11600/36550 WOS:000320768800019 |
url |
http://dx.doi.org/10.1016/j.ijcard.2011.12.097 http://repositorio.unifesp.br/handle/11600/36550 |
identifier_str_mv |
International Journal of Cardiology. Clare: Elsevier B.V., v. 167, n. 2, p. 357-361, 2013. 10.1016/j.ijcard.2011.12.097 WOS000320768800019.pdf 0167-5273 WOS:000320768800019 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
International Journal of Cardiology |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy |
dc.format.none.fl_str_mv |
357-361 application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier B.V. |
publisher.none.fl_str_mv |
Elsevier B.V. |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268415982960640 |